Japan Medical Isotope Technology Development

Japan Medical Isotope Technology Development is a private Japanese radiopharmaceutical technology company focused on medical isotopes and radioactive pharmaceuticals. The company was established in 2019 and is based in Tokyo, with a business scope that includes manufacturing and sale of medical isotopes and radiopharmaceuticals as well as related technology development. JAMIT has been visible through its role in launching Fuzionaire Radioisotope Technologies in Japan together with Fuzionaire Diagnostics to commercialize fluorine-18 radiolabeling technologies and explore alpha-emitting radiotherapeutics. Publicly available information suggests JAMIT operates primarily as an enabling radiopharma development and commercialization vehicle rather than as a company with a broadly disclosed in-house clinical pipeline. It appears positioned at the intersection of isotope supply, radiochemistry, and nuclear medicine innovation in Japan.